Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Cavco Industries
CVCO
$4.65B
| $1.58M | ﹤0.01% |
3,546
-1,200
| -25% | -$551K |
|
2202
iShares US Financials ETF
IYF
$4.43B
| $1.58M | ﹤0.01% |
14,300
+6,200
| +77% | +$690K |
|
2203
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
| $1.57M | ﹤0.01% |
+121,062
| New | +$1.63M |
|
|
OSG
2204
Octave Specialty Group
OSG
$221M
| $1.57M | ﹤0.01% |
124,200
-165,300
| -57% | -$1.99M |
|
2205
Gates Industrial Corporation Ltd.
GTES
$7.03B
| $1.57M | ﹤0.01% |
76,200
-445,800
| -85% | -$9M |
|
2206
Design Therapeutics
DSGN
$928M
| $1.56M | ﹤0.01% |
253,500
-20,500
| -7% | -$119K |
|
2207
Global X Lithium & Battery Tech ETF
LIT
$1.61B
| $1.56M | ﹤0.01% |
+38,300
| New | +$1.69M |
|
2208
SI-BONE Inc
SIBN
$848M
| $1.56M | ﹤0.01% |
+111,400
| New | +$1.5M |
|
2209
iShares Europe ETF
IEV
$1.7B
| $1.56M | ﹤0.01% |
30,000
-10,900
| -27% | -$596K |
|
|
PVBC
2210
DELISTED
Provident Bancorp
PVBC
| $1.56M | ﹤0.01% |
136,772
+10,100
| +8% | +$112K |
|
2211
ArcelorMittal
MT
$55.7B
| $1.56M | ﹤0.01% |
67,400
+2,829
| +4% | +$69.8K |
|
2212
Upland Software
UPLD
$15.7M
| $1.56M | ﹤0.01% |
35,881
+6,669
| +23% | +$216K |
|
2213
NWPX Infrastructure Inc
NWPX
$1.12B
| $1.55M | ﹤0.01% |
32,200
+21,400
| +198% | +$1.07M |
|
2214
Astec Industries
ASTE
$997M
| $1.55M | ﹤0.01% |
+46,192
| New | +$1.6M |
|
2215
Gossamer Bio
GOSS
$75.4M
| $1.55M | ﹤0.01% |
1,712,503
-32,302
| -2% | -$27.7K |
|
2216
AmeriServ Financial
ASRV
$85M
| $1.55M | ﹤0.01% |
577,574
-11,246
| -2% | -$31.3K |
|
2217
Stoneridge
SRI
$205M
| $1.54M | ﹤0.01% |
246,100
+171,700
| +231% | +$1.32M |
|
|
LX
2218
LexinFintech Holdings
LX
$224M
| $1.54M | ﹤0.01% |
265,700
-1,204,700
| -82% | -$5.06M |
|
2219
Companhia Siderúrgica Nacional
SID
$1.17B
| $1.54M | ﹤0.01% |
1,070,000
-277,913
| -21% | -$544K |
|
2220
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $1.54M | ﹤0.01% |
+11,900
| New | +$1.59M |
|
2221
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.3B
| $1.54M | ﹤0.01% |
+16,900
| New | +$1.59M |
|
2222
Everspin Technologies
MRAM
$460M
| $1.53M | ﹤0.01% |
239,967
-24,800
| -9% | -$154K |
|
|
TE
2223
T1 Energy
TE
$1.51B
| $1.53M | ﹤0.01% |
592,986
+563,086
| +1,883% | +$945K |
|
2224
Caesarstone
CSTE
$119M
| $1.53M | ﹤0.01% |
359,302
-11,716
| -3% | -$51.5K |
|
2225
Oppenheimer Holdings
OPY
$1.25B
| $1.53M | ﹤0.01% |
23,800
-25,300
| -52% | -$1.47M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.